Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Phase II SBIR grant awarded to 3-D for GPCRs

March 6, 2000

Collaboration between Novartis and Emisphere extended to include second compound

March 3, 2000

Vertex enters genomic partnership with Incyte

March 3, 2000

Successful clinical results with IDEA's drug delivery system trigger payment from P&G

March 2, 2000

Human Genome Sciences and CAT to collaborate on antibody development program

March 2, 2000

Abgenix extends antibody collaboration with Pfizer

Feb. 29, 2000

Vical, Human Genome Sciences and Vascular Genetics form collaboration

Feb. 29, 2000

High-affinity, selective human A3 receptor radioligand: synthesis and preliminary testing

Feb. 28, 2000

Oxford BioMedica to collaborate with AstraZeneca in drug discovery

Feb. 25, 2000

Corixa subscribes to Incyte's LifeSeq Gold database

Feb. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...